Global Expertise

Extensive practice in intellectual property counseling

RatnerPrestia is a law firm expert in all things IP. The Firm handles procurement, enforcement, licensing, commercialization, global strategic IP planning, and all related business aspects of IP. The Firm has attorneys experienced and successful in all relevant U.S. and German agencies and tribunals, including the U.S. Patent and Trademark Office, The German Patent Office, The European Patent Office, The U.S. International Trade Commission, and Federal Courts, both trial and appellate, in both the U.S. and Germany. This expertise extends to all areas of IP protection, including patent, design, copyright, software, trademark, and trade secret protection.

Meet the RatnerPrestia Team

Practice Areas

The professionals at RatnerPrestia have profound experience in IP law and technology. But we go beyond just being IP experts. We understand the role IP plays in business success. And in your success.

Our lawyers are leaders in their respective fields, practicing law as well as shaping it. Our services include contributions to all stages of your innovation model, and include cradle-to-grave counseling for intelligent protection, enforcement, litigation, licensing and commercialization strategies. Read More

Post Grant Practice

Litigation at the Patent Office

The face of patent litigation is changing, and RatnerPrestia’s attorneys are at the forefront of that change. There is a significant chance that all or part of your patent infringement battle will be waged at the Patent Office. Post grant proceedings—including inter partes review, post grant review, covered business methods—can resolve the issue of patent validity faster than district court litigation and at a fraction of the cost. RatnerPrestia is adept at representing patent challengers (petitioners) and owners alike in these proceedings. Read More

RP News

Supreme Court Strikes Down Lanham Act’s “Disparagement Clause” for Violating the First AmendmentRead More

Supreme Court Issues Important Decision in the Biopharma Sector Favoring Earlier Entrance of Cost-Saving Biosimilars into the US MarketRead More

Rohini K. Garg Joins RatnerPrestia as Patent AgentRead More

Jonathan H. Spadt Participates in the 34th Annual Congress-Bundestag SeminarRead More


Jonathan H. Spadt Participates in the 34th Annual Congress-Bundestag Seminar

Press Release


Rohini K. Garg Joins RatnerPrestia as Patent Agent

Press Release